| Over a month ago |
|
Hot Stocks
|
West Pharmaceutical… West Pharmaceutical appointed CFO Bernard Birkett to a newly combined position of Chief Financial and Operations Officer. The company's Senior VP, Chief Global Operations and Supply Chain Officer, David Montecalvo has announced his resignation to pursue other interests with a departure of July to ensure a seamless transition. West's Senior VP, Global Markets and Commercial Solutions, Cindy Reiss-Clark, has been appointed to the role of Chief Commercial Officer. Additionally, West's Senior VP, Commercial Products and Emerging Markets, Chris Ryan has been appointed to Senior VP, Containment and Glass Systems. The Company has also hired Kathy dePadua as VP and Chief Quality Officer. dePadua joins West from GE Healthcare where she most recently held the position of Global Quality Executive for the Life Care Solutions Strategic business unit. ShowHide Related Items >><< - 04/07/22
- West Pharmaceutical partners with Pneuma Systems for drug delivery solutions
- 02/28/22
- West Pharmaceutical names Eric Green as Chair of Board
- 01/25/22
- West Pharmaceutical enters supply, technology agreement with Corning
- 04/28/22
- West Pharmaceutical ups FY22 adjusted EPS view to $9.30-$9.45 from $9.20-$9.35
- 04/28/22
- West Pharmaceutical reports Q1 EPS $2.30, consensus $2.12
- 02/17/22
- West Pharmaceutical sees FY22 EPS $9.20-$9.35, consensus $9.06
- 02/17/22
- West Pharmaceutical reports Q4 adjusted EPS $2.04, consensus $1.91
- 11/26/21
- Early notable gainers among liquid option names on November 26th
- 11/16/21
- Early notable gainers among liquid option names on November 16th
|
|
Hot Stocks
|
Avantor and Cytovance… Avantor and Cytovance Biologics, have entered into an agreement to manufacture, research and GMP grade plasmids for biopharma customers. This collaboration extends Avantor's leadership in providing critical materials for next-generation vaccines and therapeutics focused on cell and gene therapy and mRNA drug manufacturing and expands Cytovance Biologics' global commercial reach. Plasmid DNA is one of the most critical process elements in viral vector-based gene therapy and mRNA vaccines and therapeutics. This new relationship will allow Avantor to provide global biopharma customers and contract manufacturing organizations access to plasmid DNA and other mission-critical inputs used in research, clinical testing and manufacturing scale-up and commercialization by leveraging Cytovance Biologics' plasmid cGMP manufacturing capabilities. ShowHide Related Items >><< - 05/04/22
- Avantor to create new manufacturing, distribution hub in Singapore
- 02/15/22
- Avantor chairman Rajiv Gupta to retire
- 02/11/22
- Avantor starts construction on new distribution center in Ireland
- 11/15/21
- Third Point buys Alight, exits Uber in Q3
- 04/19/22 Cowen
- Avantor price target lowered to $44 from $50 at Cowen
- 04/18/22 Evercore ISI
- Avantor added to 'TAP Outperform' list at Evercore ISI
- 04/04/22 Evercore ISI
- Avantor price target lowered, removed from 'TAP Outperform' list at Evercore ISI
- 04/04/22 Citi
- Avantor downgraded to Neutral on 'number of headwinds' at Citi
- 04/28/22
- Avantor reports Q1 adjusted EPS 38c, consensus 36c
- 02/03/22
- Avantor reports Q4 adjusted EPS 36c, consensus 33c
|
|
Hot Stocks
|
Avantor announced it will… Avantor announced it will create a new manufacturing and distribution hub in Singapore by integrating its existing distribution facility with new manufacturing operations. The new hub, which brings Avantor solutions closer to regional customers and strengthens global supply chain capabilities, will be fully operational early next year. The new hub will provide a range of services including quality control and inventory management expertise, and feature cGMP manufacturing suites and testing labs for process ingredients and excipients. ShowHide Related Items >><< - 02/15/22
- Avantor chairman Rajiv Gupta to retire
- 02/11/22
- Avantor starts construction on new distribution center in Ireland
- 11/15/21
- Third Point buys Alight, exits Uber in Q3
- 04/19/22 Cowen
- Avantor price target lowered to $44 from $50 at Cowen
- 04/18/22 Evercore ISI
- Avantor added to 'TAP Outperform' list at Evercore ISI
- 04/04/22 Evercore ISI
- Avantor price target lowered, removed from 'TAP Outperform' list at Evercore ISI
- 04/04/22 Citi
- Avantor downgraded to Neutral on 'number of headwinds' at Citi
- 04/28/22
- Avantor reports Q1 adjusted EPS 38c, consensus 36c
- 02/03/22
- Avantor reports Q4 adjusted EPS 36c, consensus 33c
|
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 04/29/22
- Zymeworks rises 31.7%
- 04/29/22
- Zymeworks rises 53.9%
- 04/29/22
- Zymeworks rises 48.0%
- 04/29/22
- Zymeworks receives $10.50 per share non-binding acquisition proposal from ABF
- 04/29/22
- Exxon Mobil reports Q1 free cash flow 10.84B
- 04/29/22
- Exxon Mobil CEO sees 'positive momentum for the second quarter'
- 04/29/22
- Exxon Mobil increases share repurchase program to $30B through 2023
- 04/28/22
- California AG announces investigation into fossil fuel, petrochemical industries
- 04/29/22
- Western Union falls -8.1%
- 04/29/22
- Western Union expands collaboration with UK Post Office
- 03/28/22
- Western Union expands in South Korea with ICB
- 03/23/22
- Western Union announces Artajasa Pembayaran Elektronis as partner in Indonesia
- 04/29/22
- Wipro sees Q1 IT Services revenue $2.748B-$2.803B
- 04/26/22
- Wipro to acquire Rizing from One Equity Partners, terms not disclosed
- 04/26/22
- One Equity Partners to sell Rizing to Wipro, terms not disclosed
- 04/11/22
- Wipro acquires Convergence Acceleration Solutions, terms undisclosed
- 03/31/22
- Weibo announces $500M share repurchase program
- 03/24/22
- Weibo provides update on status under Holding Foreign Companies Accountable Act
- 03/23/22
- Weibo drops 4% after SEC adds to HFCAA provisional list
- 03/23/22
- Weibo added to SEC provisional list of companies under HFCAA
- 04/29/22
- Elon Musk sold over $8B of Tesla shares following Twitter bid
- 04/29/22
- Musk sold about $4B in Tesla stock after agreeing to buy Twitter
- 04/29/22
- Cathie Wood says Tesla will probably stay largest portfolio position
- 04/29/22
- Cathie Wood has not lost confidence in Tesla, says Musk should diversify
- 04/29/22
- Tesla up 3% to $899.91 after Musk says no further sales planned
- 04/29/22
- Elon Musk says no further Tesla share sales planned
- 04/29/22
- TAL Education extends share repurchase program
- 02/25/22
- TAL Education falls -11.0%
- 02/15/22
- TAL Education rises 21.9%
- 02/15/22
- TAL Education rises 13.5%
- 04/28/22
- Roku reports Q1 platform revenue up 39% to $647M
- 04/21/22
- Cathie Wood's ARK Investment bought 200.1K shares of Roku today
- 04/20/22
- Cathie Wood's ARK Investment bought 375.5K shares of Roku today
- 04/19/22
- Roku drops 6% to $109.96 after Netflix losses subscribers in Q1
- 04/28/22
- Rivian Automotive, Clearloop partner on renewable electricity
- 04/14/22
- Rivian Automotive appoints Anisa Kamadoli Costa as chief sustainability officer
- 04/05/22
- Rivian Automotive reports Q1 production of 2,553 vehicles
- 03/31/22
- Biden authorizing Defense Production Act for American production of EV materials
- $43.12 /
+5.165 (+13.61%) - 03/21/22
- Pinduoduo deepens agricultural digital inclusion efforts in 3031
- 03/01/22
- Pinduoduo, FAO China organize webinar on smart agriculture
- 12/02/21
- U.S. 'step closer' to delisting Chinese companies as SEC finalizes rules
- 11/26/21
- Pinduoduo targets increased investment in R&D, plans to promote young talent
- 04/28/22
- Olin, Plug Power partner to produce green hydrogen
- 04/28/22
- Olin sees Q2 results higher than Q1
- 03/31/22
- Olin, Mitsui announce blue water joint venture
- 03/14/22
- Olin temporarily curtailing integrated epoxy production at German facility
- 04/20/22
- Pershing Square sells Netflix investment
- 04/19/22
- Netflix says will figure out advertising in next year or two
- 04/19/22
- Netflix says Q2 typically a softer quarter seasonally
- 04/19/22
- Netflix to test ways to charge for account sharing this year
- $141.00 /
+10.19 (+7.79%) - 04/29/22
- Mohawk Industries rises 17.6%
- 04/29/22
- Mohawk Industries rises 16.1%
- 04/28/22
- Mohawk Industries jumps 11% to $145.00 after Q1 results beat estimates
- $363.54 /
-15.08 (-3.98%) - 04/28/22
- MasterCard sees Q2 operating expenses up at high single digit rate
- 04/28/22
- MasterCard sees Q2 y/y net revenue at high end of high teens rate
- 04/28/22
- MasterCard sees FY22 net revenue up at high end of high teens rate
- 04/28/22
- MasterCard to be network on Verizon's small business credit card, CEO says
- 04/29/22
- LianBio announces FDA approved Camzyos
- 04/27/22
- MeiraGTx appoints Debra Yu to board of directors
- 04/07/22
- LianBio partner ReViral expected to be acquired by Pfizer
- 04/07/22
- LianBio appoints Chen to board of directors
- $61.71 /
+3.9299 (+6.80%) - 04/06/22
- JD.com names Lei Xu as new CEO
- 03/13/22
- Fly Intel: Top five weekend stock stories
- 03/13/22
- JD.com announces proposed acquisition of Deppon Logistics by JD Logistics
- 04/28/22
- Intel CEO: Q1 was a strong start to the year, exceeded expectations
- 04/28/22
- Intel reaffirms FY22 revenue guidance
- 04/25/22
- Tower Semiconductor shareholders approve Intel merger agreement
- 04/20/22
- Semtech announces Julie McGee as chief marketing officer
- 04/26/22
- HSBC: Revenue outlook remains 'positive,' sees MSD revenue growth in 2022
- 04/18/22
- Plug Power appoints Jean Bua, Kavita Mahtani to board of directors
- 03/29/22
- HSBC, IBM to explore applications for quantum computing in financial services
- 03/16/22
- HSBC Bank USA, affiliates raise prime and reference rate to 3.5% from 3.25%
- 04/13/22
- Honeywell announces new sustainability commitments
- 03/25/22
- Brady secures license to Honeywell global shutter barcode technology
- 03/09/22
- Honeywell suspends substantially all business in Russia, Belarus
- 03/08/22
- Honeywell, DESS partner on energy resiliency solutions
- 04/28/22
- Fortune Brands announces intent to separate into two separate companies
- 04/28/22
- Fortune Brands announces intent to separate into two separate companies
- 03/02/22
- Fortune Brands announces $750M share repurchase authorization
- 02/07/22
- Fortune Brands names May Russell chief digital officer
- 04/29/22
- Eldorado Gold falls -10.7%
- 04/28/22
- Eldorado Gold still sees 2022 gold production 460K-490K oz.
- 04/13/22
- Eldorado Gold reports preliminary Q1 gold production 93,209 ounces
- 02/24/22
- Eldorado Gold sees 2022 gold production 460K-490K
- 04/29/22
- Deutsche Bank says cooperating with Frankfurt suspicious activity probe
- 04/27/22
- Deutsche Bank aims to achieve cumulative volumes of over EUR 200B by year-end
- 03/23/22
- Deutsche Bank to raise pay for Postbank employees
- 03/17/22
- Deutsche Bank increases prime lending rate to 3.50%
- 04/29/22
- Chevron sees FY22 CapEx more than 50% higher than FY21
- 04/29/22
- Chevron reports Q1 cash flow from operations $8.1B, free cash flow $6.1B
- 04/26/22
- Lincoln Electric collaborates with Chevron for refinery maintenance
- 03/20/22
- Fly Intel: Top five weekend stock stories
- 04/06/22
- Peacock to stream MLB games on Sunday mornings starting May 8
- 04/27/22
- Comcast, Charter form joint venture to develop streaming platform
- 04/26/22
- Nintendo says 'Mario Bros.' movie pushed by Spring 2023
- 04/24/22
- Fly Intel: Top five weekend stock stories
- 04/20/22
- Comcast announces $1M investment in Backstage Capital
- 04/29/22
- Clearwater Paper rises 21.1%
- 04/29/22
- Clearwater Paper rises 17.0%
- 04/28/22
- Clearwater Paper sees Q2 adjusted EBITDA of $54M-$64M
- 04/28/22
- Clearwater Paper says resuming previously approved buyback
- 04/01/22
- Carlyle enters into strategic advisory services agreement with Fortitude Re
- 03/09/22
- Carlyle Group to acquire CBAM Partners' portfolio of assets
- 03/07/22
- AZZ Inc. to acquire Precoat Metals from Sequa Corporation for $1.28B
- 02/14/22
- Apollo Global to acquire majority stake in Novolex, terms not disclosed
- 04/28/22
- FDA approves Bristol-Myers' Camzyos in adults with obstructive HCM
- 04/18/22
- Bristol-Myers to begin including R&D charges with Q1, sees 10c impact from IPRD
- 04/14/22
- Nektar, Bristol-Myers to end development program for bempegaldesleukin/Opdivo
- 03/22/22
- Alibaba up 9.5% to $113.40 after the company expanded its buyback to $25B
- 03/21/22
- Alibaba increases stock buyback program to $25B from $15B
- 03/10/22
- BeiGene, Yum China, Zai Lab, ACM Research, Hutchmed named to SEC HFCAA list
- 02/17/22
- Atlas Air, Cainiao expand partnership with Boeing Freighter
- 02/15/22
- Avantor chairman Rajiv Gupta to retire
- 02/11/22
- Avantor starts construction on new distribution center in Ireland
- 11/15/21
- Third Point buys Alight, exits Uber in Q3
- $2,485.59 /
-400.92 (-13.89%) - 04/29/22
- Cathie Wood sees Teladoc as similar to Amazon.com
- 04/29/22
- Victoria's Secret & PINK Beauty launch in Amazon's store
- 04/28/22
- Amazon.com says customer demand 'remains strong'
- 04/28/22
- Amazon.com says Prime members continue to be key driver of growth
- 04/13/22
- Accolade announces partnership with Priority Health
- $146.88 /
-9.515 (-6.08%) - 04/29/22
- AbbVie's RINVOQ approved by FDA for treatment of active AS
- 04/29/22
- AbbVie says no plans to cut R&D investments in 2023
- 04/29/22
- AbbVie says cystic fibrosis combination drug missed study goal
- 04/29/22
- AbbVie says confident in long-term fundamentals of business
- 04/28/22
- Apple says COVID is 'difficult to predict'
- 04/28/22
- Apple turns lower, down nearly 4% in after-hours amid quarterly call
- 04/28/22
- Apple says iPhone acting install base reached new all-time high
- 04/28/22
- Apple shares rally 2% to $167.10 following Q2 beat, buyback raise
- 04/11/22 UBS
- Alibaba price target lowered to $140 from $150 at UBS
- 04/10/22 Goldman Sachs
- Alibaba assumed with a Buy at Goldman Sachs
- 04/08/22 HSBC
- Alibaba price target lowered to $156 from $168 at HSBC
- 04/07/22 Benchmark
- Alibaba price target lowered to $220 from $235 at Benchmark
- $43.12 /
+5.165 (+13.61%) - 04/29/22 86 Research
- Pinduoduo upgraded to Buy from Hold at 86 Research
- 04/10/22 Goldman Sachs
- Pinduoduo assumed with a Buy at Goldman Sachs
- 03/23/22 UBS
- UBS upgrades Pinduoduo to Buy on gross margin expansion offsetting slower growth
- 03/23/22 UBS
- Pinduoduo upgraded to Buy from Neutral at UBS
- $61.71 /
+3.9299 (+6.80%) - 04/13/22 CLSA
- JD.com price target lowered to $100 from $108 at CLSA
- 03/16/22 US Tiger
- China Internet sector upgraded to Outperform from Neutral at US Tiger
- 03/14/22 JPMorgan
- JPMorgan downgrades Dada Nexus to Neutral, prefers over smaller peer Dingdong
- 03/14/22 JPMorgan
- JD.com downgraded to Underweight from Overweight at JPMorgan
- 04/10/22 Goldman Sachs
- Weibo assumed with a Neutral at Goldman Sachs
- 03/14/22 JPMorgan
- Weibo price target lowered to $24 from $32 at JPMorgan
- 03/11/22 UBS
- Weibo downgraded to Neutral at UBS on weaker ad growth and margin outlook
- 03/11/22 UBS
- Weibo downgraded to Neutral from Buy at UBS
- 04/29/22 Evercore ISI
- Apple still well positioned for low double digit EPS growth, says Evercore ISI
- 04/29/22 Wells Fargo
- Apple's Q2 results 'solid' amid worsening supply chain impacts, says Wells Fargo
- 04/29/22 Baird
- Apple weakness would be a buying opportunity, says Baird
- 04/29/22 Deutsche Bank
- Apple price target lowered to $200 from $210 at Deutsche Bank
- $2,485.59 /
-400.92 (-13.89%) - 04/29/22 Truist
- Amazon.com price target lowered to $3,500 from $4,000 at Truist
- 04/29/22 Evercore ISI
- Amazon price target lowered to $4,100 from $4,300 at Evercore ISI
- 04/29/22 DA Davidson
- Amazon.com price target lowered to $3,125 from $3,900 at DA Davidson
- 04/29/22 BMO Capital
- Amazon.com price target lowered to $3,450 from $3,650 at BMO Capital
- 04/26/22 Barclays
- Rivian Automotive price target lowered to $38 from $42 at Barclays
- 04/25/22 JPMorgan
- Ford price target lowered to $21 from $22 at JPMorgan
- 04/21/22 Deutsche Bank
- Rivian Automotive price target lowered to $90 from $91 at Deutsche Bank
- 04/20/22 Mizuho
- Rivian Automotive price target lowered to $90 from $95 at Mizuho
- 04/27/22 Wedbush
- Twitter transaction 'was never ideal' for Tesla investors, says Wedbush
- 04/26/22 Wedbush
- 'Soap opera' now ends with Musk owning Twitter, says Wedbush
- 04/25/22 Gordon Haskett
- Twitter bid more attractive after market selloff, says Gordon Haskett
- 04/25/22 Wedbush
- Twitter bid unlikely to result in major sale of Musk's Tesla stock, says Wedbush
- 04/29/22 Evercore ISI
- Evercore 'impressed' by Snap's product innovation after partner summit
- 04/28/22 Piper Sandler
- Twitter price target raised to $51.50 from $46 at Piper Sandler
- 04/26/22 Wedbush
- Twitter price target raised to $54 from $42 at Wedbush
- 04/29/22 Northland
- Intel Q2 guidance looks conservative, says Northland
- 04/27/22 Lynx
- Lynx sees China supply risks extending into Q3
- 04/14/22 Credit Suisse
- TSMC results may give 'tactical reprieve' to U.S. Semis, says Credit Suisse
- 04/12/22 Citi
- Citi sees 'another yellow flag' for Intel, reiterates Neutral
- 04/21/22 Truist
- Chevron price target raised to $186 from $160 at Truist
- 04/21/22 RBC Capital
- Chevron downgraded to Sector Perform from Outperform at RBC Capital
- 04/05/22 UBS
- Chevron price target raised to $192 from $150 at UBS
- 03/14/22 Morgan Stanley
- Chevron downgraded to Equal Weight at Morgan Stanley after outperformance
- 04/21/22 Truist
- Exxon Mobil price target raised to $84 from $75 at Truist
- 04/21/22 RBC Capital
- Exxon Mobil upgraded to Outperform from Sector Perform at RBC Capital
- 04/29/22 SVB Securities
- Accolade downgraded to Market Perform from Outperform at SVB Leerink
- 04/29/22 Stifel
- Accolade removed from 'Select List,' price target lowered to $16 at Stifel
- 04/29/22 Canaccord
- Accolade price target lowered to $17 from $34 at Canaccord
- 04/29/22 Needham
- Accolade price target lowered to $12 from $33 at Needham
- 04/29/22 Morgan Stanley
- Comcast price target lowered to $55 from $60 at Morgan Stanley
- 04/29/22 Deutsche Bank
- Comcast price target lowered to $60 from $62 at Deutsche Bank
- 04/29/22 BTIG
- Accolade downgraded to Neutral from Buy at BTIG
- 04/14/22 Oppenheimer
- Comcast price target lowered to $60 from $75 at Oppenheimer
- 03/23/22 Craig-Hallum
- ComScore poised for share gains in local measurement, says Craig-Hallum
- $363.54 /
-15.08 (-3.98%) - 04/29/22 BMO Capital
- MasterCard price target lowered to $402 from $412 at BMO Capital
- 04/29/22 Deutsche Bank
- MasterCard price target raised to $440 from $420 at Deutsche Bank
- 04/29/22 Citi
- MasterCard price target raised to $453 from $435 at Citi
- 04/29/22 JPMorgan
- MasterCard price target raised to $430 from $400 at JPMorgan
- 04/29/22 Benchmark
- Benchmark 'incrementally more confident' in improving Roku growth after Q1
- 04/29/22 DA Davidson
- Roku price target lowered to $170 from $200 at DA Davidson
- 04/29/22 Stephens
- Roku price target lowered to $190 from $230 at Stephens
- 04/29/22 Oppenheimer
- Roku price target lowered to $155 from $185 at Oppenheimer
- 04/29/22 Truist
- Fortune Brands price target lowered to $100 from $115 at Truist
- 04/29/22 BofA
- Fortune Brands upgraded to Neutral at BofA on cabinets spinoff plan
- 04/29/22 BofA
- Fortune Brands upgraded to Neutral from Underperform at BofA
- 04/29/22 KeyBanc
- Fortune Brands downgraded to Sector Weight from Overweight at KeyBanc
- 04/21/22 Benchmark
- Roku price target lowered to $240 from $305 at Benchmark
- 04/21/22 Citi
- Netflix price target lowered to $295 from $450 at Citi
- 04/21/22 Edward Jones
- Netflix downgraded to Hold from Buy at Edward Jones
- 04/21/22 DZ Bank
- Netflix downgraded to Hold from Buy at DZ Bank
- 04/27/22 Credit Suisse
- HSBC price target lowered to 515 GBp from 530 GBp at Credit Suisse
- 04/20/22 Barclays
- HSBC price target raised to 735 GBp from 725 GBp at Barclays
- 03/14/22 JPMorgan
- HSBC price target lowered to 510 GBp from 570 GBp at JPMorgan
- 03/04/22 RBC Capital
- HSBC price target raised to 570 GBp from 530 GBp at RBC Capital
- 04/29/22 UBS
- Deutsche Bank price target raised to EUR 16.30 from EUR 15.30 at UBS
- 04/28/22 RBC Capital
- Deutsche Bank price target raised to EUR 13 from EUR 12.50 at RBC Capital
- 04/21/22 Morgan Stanley
- Deutsche Bank price target lowered to EUR 14.90 at Morgan Stanley
- 04/04/22 JPMorgan
- Deutsche Bank price target raised to EUR 15 from EUR 14 at JPMorgan
- 03/15/22 Evercore ISI
- Zymeworks initiated with an Outperform at Evercore ISI
- 02/28/22 Piper Sandler
- Piper Sandler recommends ALX Oncology shares following 'quiet' Q4
- 02/28/22 Citi
- Zymeworks price target lowered to $30 from $53 at Citi
- 02/09/22 Wells Fargo
- Zymeworks price target lowered to $45 from $56 at Wells Fargo
- 03/09/22 Daiwa
- TAL Education upgraded to Buy from Neutral at Daiwa
- 03/07/22 Morgan Stanley
- Youdao upgraded to Overweight from Equal Weight at Morgan Stanley
- 03/07/22 Morgan Stanley
- TAL Education upgraded to Overweight from Underweight at Morgan Stanley
- 04/14/22 JPMorgan
- Olin added to Analyst Focus List at JPMorgan
- 03/14/22 KeyBanc
- KeyBanc upgrades Olin to Overweight with $64 price target
- 03/14/22 KeyBanc
- Olin upgraded to Overweight from Sector Weight at KeyBanc
- 01/31/22 Fermium Research
- Olin price target raised to $70 from $60 at Fermium Research
- $141.00 /
+10.19 (+7.79%) - 04/21/22 Wells Fargo
- Mohawk Industries price target lowered to $135 from $155 at Wells Fargo
- 04/20/22 JPMorgan
- Mohawk Industries price target lowered to $127 from $140 at JPMorgan
- 04/12/22 Loop Capital
- Mohawk Industries price target lowered to $130 from $165 at Loop Capital
- 04/05/22 Credit Suisse
- Mohawk Industries initiated with a Neutral at Credit Suisse
- 04/19/22 Cowen
- Avantor price target lowered to $44 from $50 at Cowen
- 04/18/22 Evercore ISI
- Avantor added to 'TAP Outperform' list at Evercore ISI
- 04/04/22 Evercore ISI
- Avantor price target lowered, removed from 'TAP Outperform' list at Evercore ISI
- 04/04/22 Citi
- Avantor downgraded to Neutral on 'number of headwinds' at Citi
- 11/26/21 BofA
- LianBio initiated with a Buy at BofA
- 11/26/21 Goldman Sachs
- LianBio initiated with a Neutral at Goldman Sachs
- 11/26/21 Jefferies
- LianBio initiated with a Buy at Jefferies
- 11/24/21 Raymond James
- LianBio initiated with an Outperform at Raymond James
- 04/18/22 Goldman Sachs
- Nektar downgraded to Sell from Neutral at Goldman Sachs
- 04/18/22 Mizuho
- Nektar price target lowered to $6 from $8 at Mizuho
- 04/06/22 Morgan Stanley
- Bristol-Myers assumed with an Underweight at Morgan Stanley
- 03/30/22 BMO Capital
- Bristol-Myers price target raised to $81 from $74 at BMO Capital
- 04/29/22 Citi
- Citi downgrades Western Union to Neutral, sees shares being range-bound
- 04/29/22 Citi
- Western Union downgraded to Neutral from Buy at Citi
- 04/29/22 JPMorgan
- Western Union price target lowered to $19 from $20 at JPMorgan
- 03/31/22 UBS
- Western Union initiated with a Neutral at UBS
- 04/20/22 National Bank
- Eldorado Gold price target raised to C$20 from C$18 at National Bank
- 02/08/22 Stifel
- Eldorado Gold price target lowered to C$20.25 from C$21.50 at Stifel
- 02/04/22 National Bank
- Eldorado Gold price target raised to C$17 from C$16 at National Bank
- 01/19/22 National Bank
- Eldorado Gold price target lowered to C$16 from C$17.50 at National Bank
- 04/14/22 Deutsche Bank
- Honeywell price target lowered to $230 from $243 at Deutsche Bank
- 04/14/22 Deutsche Bank
- Honeywell named short-term buy idea at Deutsche Bank
- 03/28/22 Cowen
- Honeywell first half consensus may be too high, says Cowen
- 03/04/22 Deutsche Bank
- Honeywell price target raised to $243 from $237 at Deutsche Bank
- $146.88 /
-9.515 (-6.08%) - 04/29/22 Piper Sandler
- Piper says buy AbbVie 'right here' despite 'disappointing' Q1
- 04/29/22 Piper Sandler
- AbbVie data miss removes primary Vertex overhang, says Piper Sandler
- 04/25/22 BMO Capital
- AbbVie price target raised to $174 from $161 at BMO Capital
- 04/22/22 Piper Sandler
- Biohaven widening lead over AbbVie in migraine, says Piper Sandler
- 04/11/22 Macquarie
- Wipro initiated with a Neutral at Macquarie
- 02/21/22 CLSA
- Wipro upgraded to Outperform from Underperform at CLSA
- 02/04/22 Jefferies
- Wipro upgraded to Hold yesterday at Jefferies following 20% correction
- 02/03/22 Jefferies
- Wipro upgraded to Hold from Underperform at Jefferies
- 04/29/22 BMO Capital
- Carlyle Group price target lowered to $60 from $69 at BMO Capital
- 04/22/22 BMO Capital
- Blackstone price target raised to $142 from $124 at BMO Capital
- 04/13/22 Oppenheimer
- Carlyle Group price target raised to $80 from $71 at Oppenheimer
- 04/13/22 Oppenheimer
- Oppenheimer upgrades Apollo Global following 23% year-to-date pullback
- 02/16/22 BMO Capital
- Clearwater Paper upgraded to Outperform at BMO amid 'overdone' move lower
- 02/16/22 BMO Capital
- Clearwater Paper upgraded to Outperform from Market Perform at BMO Capital
- 02/16/22 RBC Capital
- Clearwater Paper cut to Sector Perform at RBC Capital on likely lower cash flow
- 02/16/22 RBC Capital
- Clearwater Paper downgraded to Sector Perform from Outperform at RBC Capital
- 02/24/22
- Zymeworks reports Q4 EPS (95c), consensus ($1.14)
- 11/03/21
- Zymeworks reports Q3 EPS ($1.25), consensus ($1.17)
- 04/29/22
- Exxon Mobil reports Q1 adjusted EPS $2.07, consensus $2.12
- 02/01/22
- Exxon Mobil reports Q4 ex-items EPS $2.05, consensus $1.93
- 04/28/22
- Western Union cuts FY22 adjusted EPS view to $1.75-$1.85 from $1.90-$2.00
- 04/28/22
- Western Union reports Q1 adjusted EPS 51c, consensus 43c
- 02/10/22
- Western Union sees FY22 adjusted EPS $1.90-$2.00, consensus $2.24
- 04/29/22
- Wipro reports Q4 EPS 7c, two estimates 8c
- 01/12/22
- Wipro reports Q3 EPS 7c, consensus 8c
- 03/03/22
- Weibo reports Q4 EPS 83c, consensus 81c
- 11/11/21
- Weibo sees Q4 revenue up 15%-20%, consensus $594.3M
- 11/11/21
- Weibo reports Q3 EPS 90c, consensus 84c
- 04/28/22
- Twitter withdrawing previously provided outlook given pending acquisition
- 04/28/22
- Twitter reports Q1 EPS 90c, consensus 3c
- 02/10/22
- Twitter expects FY22 revenue growth in low to mid 20's range
- 02/10/22
- Twitter sees Q1 revenue $1.17B-$1.27B, consensus $1.26B
- 04/20/22
- Tesla reports Q1 EPS $3.22, consensus $2.26
- 04/20/22
- Notable companies reporting after market close
- 01/26/22
- Tesla reports Q4 non-GAAP EPS $2.54, consensus $2.26
- 01/26/22
- Notable companies reporting after market close
- 04/29/22
- TAL Education reports Q4 EPS (17c), consensus (12c)
- 02/22/22
- TAL Education reports Q3 EPS 9c, consensus 3c
- 04/28/22
- Roku backs FY22 revenue growth view of 35% y/y, consensus $3.72B
- 04/28/22
- Roku sees Q2 revenue $805M, consensus $815.7M
- 04/28/22
- Roku reports Q1 EPS (19c), consensus (18c)
- 03/10/22
- Rivian sees FY22 adjusted EBITDA ($4.75B)
- 03/10/22
- Rivian reports Q4 EPS ($4.83) vs ($1.97)
- 03/10/22
- Notable companies reporting after market close
- $43.12 /
+5.165 (+13.61%) - 03/21/22
- Pinduoduo reports Q4 EPS RMB 5.88 vs. (RMB 0.15) last year
- 11/26/21
- Pinduoduo reports Q3 adjusted EPS 34c, consensus 2c
- 04/28/22
- Olin reports Q1 EPS $2.48, consensus $2.35
- 01/27/22
- Olin sees FY22 adjusted EBITDA $2.5B-$2.8B
- 01/27/22
- Olin reports Q4 EPS $1.89, consensus $2.44
- 04/19/22
- Netflix sees Q2 EPS $3.00, consensus $3.01
- 04/19/22
- Netflix reports Q1 EPS $3.53, consensus $2.90
- 04/19/22
- Notable companies reporting after market close
- 01/20/22
- Netflix sees Q1 EPS $2.86, consensus $3.45
- $141.00 /
+10.19 (+7.79%) - 04/28/22
- Mohawk Industries reports Q1 adjusted EPS $3.78, consensus $2.90
- 02/10/22
- Mohawk Industries sees Q1 adjusted EPS $2.90-$3.00, consensus $3.08
- 02/10/22
- Mohawk Industries reports Q4 adjusted EPS $2.95, consensus $2.87
- $363.54 /
-15.08 (-3.98%) - 04/28/22
- MasterCard reports Q1 adjusted EPS $2.76, consensus $2.17
- 01/27/22
- MasterCard sees Q1 net revenue up in the high teens, consensus $5.07B
- 03/30/22
- LianBio reports Q4 EPS (28c), consensus (71c)
- 12/09/21
- LianBio reports Q3 EPS (63c), consensus (57c)
- $61.71 /
+3.9299 (+6.80%) - 03/10/22
- JD.com reports Q4 EPS 35c, consensus 24c
- 11/18/21
- JD.com reports Q3 EPS 25c, consensus 32c
- 11/17/21
- Notable companies reporting before tomorrow's open
- 04/28/22
- Intel sees FY22 adjusted EPS $3.60, consensus $3.50
- 04/28/22
- Intel sees Q2 adjusted EPS 70c, consensus 83c
- 04/28/22
- Intel reports Q1 adjusted EPS 87c, consensus 80c
- 04/26/22
- HSBC reports Q1 EPS 14c vs. 19c last year
- 02/23/22
- HSBC reports 2021 EPS 62c vs. 19c last year
- 04/29/22
- Honeywell sees Q2 adjusted EPS $1.98-$2.08, consensus $2.04
- 04/29/22
- Honeywell raises FY22 adjusted EPS view to $8.50-$8.80 from $8.40-$8.70
- 04/29/22
- Honeywell reports Q1 adjusted EPS $1.91, consensus $1.86
- 04/28/22
- Fortune Brands now sees FY22 EPS $6.40-$6.60, consensus $6.40
- 04/28/22
- Fortune Brands reports Q1 adjusted EPS $1.31, consensus $1.26
- 02/02/22
- Fortune Brands sees FY22 EPS $6.35-$6.55, consensus $6.31
- 04/28/22
- Eldorado Gold reports Q1 adjusted EPS (10c), consensus 7c
- 02/24/22
- Eldorado Gold reports Q4 EPS (24c), consensus 13c
- 04/27/22
- Deutsche Bank reports Q1 profit before tax EUR 1.7B, up 4% vs. last year
- 04/27/22
- Deutsche Bank reports Q1 net revenue EUR 7.3B, up 1% vs. last year
- 01/27/22
- Deutsche Bank reports FY21 net revenue EUR 25.4B, up 6% vs. FY20
- 01/27/22
- Deutsche Bank reports Q4 profit before tax EUR 82M, net profit EUR 315M
- 04/29/22
- Chevron reports Q1 adjusted EPS $3.36, consensus $3.27
- 04/28/22
- Notable companies reporting before tomorrow's open
- 01/28/22
- Chevron reports Q4 adjusted EPS $2.56, consensus $3.13
- 04/28/22
- Comcast reports Q1 adjusted EPS 86c, consensus 80c
- 04/27/22
- Notable companies reporting before tomorrow's open
- 01/27/22
- Comcast reports Q4 adjusted EPS 77c, consensus 73c
- 04/28/22
- Clearwater Paper reports Q1 EPS 97c, consensus 87c
- 02/15/22
- Clearwater Paper reports Q4 EPS 82c, consensus 79c
- 11/02/21
- Clearwater Paper sees FY21 adjusted EBITDA $167M-$175M
- 11/02/21
- Clearwater Paper sees Q4 adjusted EBITDA $48M-$56M
- 04/29/22
- Carlyle Group reports Q1 EPS 74c vs. 58c last year
- 02/02/22
- Notable companies reporting before tomorrow's open
- 04/29/22
- Bristol-Myers lowers FY22 adjusted EPS view to $7.44-$7.74 from $7.65-$7.95
- 04/29/22
- Bristol-Myers reports Q1 EPS $1.96, consensus $1.91
- 02/24/22
- Alibaba reports Q4 EPS $2.65, consensus $2.55
- 02/23/22
- Notable companies reporting before tomorrow's open
- 11/18/21
- Alibaba now sees FY22 revenue to grow 20%-23% year-over-year
- 04/28/22
- Avantor reports Q1 adjusted EPS 38c, consensus 36c
- 02/03/22
- Avantor reports Q4 adjusted EPS 36c, consensus 33c
- $2,485.59 /
-400.92 (-13.89%) - 04/28/22
- Amazon sees Q2 revenue $116B-$121B, consensus $125.55B
- 04/28/22
- Amazon reports Q1 EPS ($7.56) with Rivian expense, consensus $8.36
- 04/26/22
- Else Nutrition sees Q1 revenue top end of C$1.45M-C$1.6M
- 04/28/22
- Accolade sees FY23 revenue $350M-$365M, consensus $387.39M
- 04/28/22
- Accolade sees Q2 revenue $81M-$83M, consensus $85.91M
- 04/28/22
- Accolade reports Q4 EPS (51c), consensus (36c)
- $146.88 /
-9.515 (-6.08%) - 04/29/22
- AbbVie sees FY22 revenue $59.4B, consensus $60.22B
- 04/29/22
- AbbVie sees Q2 adjusted EPS $3.38-$3.42, consensus $3.50
- 04/29/22
- AbbVie cuts FY22 adjusted EPS view to $13.92-$14.12 from $14.00-$14.20
- 04/29/22
- AbbVie reports Q1 adjusted EPS $3.16, consensus $3.14
- 04/28/22
- Apple says y/y Q3 revenue growth to be impacted by COVID
- 04/28/22
- Apple reports Q2 EPS $1.52, consensus $1.43
- 04/28/22
- Notable companies reporting after market close
- 02/27/22
- Berkshire operating earnings surge, Buffett repurchases record $27B in stock
|
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 04/29/22
- Zymeworks rises 31.7%
- 04/29/22
- Zymeworks rises 53.9%
- 04/29/22
- Zymeworks rises 48.0%
- 04/29/22
- Zymeworks receives $10.50 per share non-binding acquisition proposal from ABF
- 04/29/22
- Western Union falls -8.1%
- 04/29/22
- Western Union expands collaboration with UK Post Office
- 03/28/22
- Western Union expands in South Korea with ICB
- 03/23/22
- Western Union announces Artajasa Pembayaran Elektronis as partner in Indonesia
- 04/29/22
- Wipro sees Q1 IT Services revenue $2.748B-$2.803B
- 04/26/22
- Wipro to acquire Rizing from One Equity Partners, terms not disclosed
- 04/26/22
- One Equity Partners to sell Rizing to Wipro, terms not disclosed
- 04/11/22
- Wipro acquires Convergence Acceleration Solutions, terms undisclosed
- $23.63 /
+2.375 (+11.17%) - 03/31/22
- Weibo announces $500M share repurchase program
- 03/24/22
- Weibo provides update on status under Holding Foreign Companies Accountable Act
- 03/23/22
- Weibo drops 4% after SEC adds to HFCAA provisional list
- 03/23/22
- Weibo added to SEC provisional list of companies under HFCAA
- 04/28/22
- Twitter admits it overstated user numbers between 2019-2021
- $905.80 /
+28.79 (+3.28%) - 04/29/22
- Tesla up 3% to $899.91 after Musk says no further sales planned
- 04/29/22
- Elon Musk says no further Tesla share sales planned
- 04/29/22
- Elon Musk sold over $8B of Tesla shares following Twitter bid
- 04/29/22
- Musk sold about $4B in Tesla stock after agreeing to buy Twitter
- 04/29/22
- TAL Education extends share repurchase program
- 02/25/22
- TAL Education falls -11.0%
- 02/15/22
- TAL Education rises 21.9%
- 02/15/22
- TAL Education rises 13.5%
- 04/28/22
- Roku reports Q1 platform revenue up 39% to $647M
- 04/21/22
- Cathie Wood's ARK Investment bought 200.1K shares of Roku today
- 04/20/22
- Cathie Wood's ARK Investment bought 375.5K shares of Roku today
- 04/19/22
- Roku drops 6% to $109.96 after Netflix losses subscribers in Q1
- 04/28/22
- Rivian Automotive, Clearloop partner on renewable electricity
- 04/14/22
- Rivian Automotive appoints Anisa Kamadoli Costa as chief sustainability officer
- 04/05/22
- Rivian Automotive reports Q1 production of 2,553 vehicles
- 03/31/22
- Biden authorizing Defense Production Act for American production of EV materials
- 03/21/22
- Pinduoduo deepens agricultural digital inclusion efforts in 3031
- 03/01/22
- Pinduoduo, FAO China organize webinar on smart agriculture
- 12/02/21
- U.S. 'step closer' to delisting Chinese companies as SEC finalizes rules
- 11/26/21
- Pinduoduo targets increased investment in R&D, plans to promote young talent
- 04/28/22
- Olin, Plug Power partner to produce green hydrogen
- 04/28/22
- Olin sees Q2 results higher than Q1
- 03/31/22
- Olin, Mitsui announce blue water joint venture
- 03/14/22
- Olin temporarily curtailing integrated epoxy production at German facility
- 04/20/22
- Pershing Square sells Netflix investment
- 04/19/22
- Netflix says will figure out advertising in next year or two
- 04/19/22
- Netflix says Q2 typically a softer quarter seasonally
- 04/19/22
- Netflix to test ways to charge for account sharing this year
- $142.67 /
+11.86 (+9.07%) - 04/29/22
- Mohawk Industries rises 17.6%
- 04/29/22
- Mohawk Industries rises 16.1%
- 04/28/22
- Mohawk Industries jumps 11% to $145.00 after Q1 results beat estimates
- 04/28/22
- MasterCard sees Q2 operating expenses up at high single digit rate
- 04/28/22
- MasterCard sees Q2 y/y net revenue at high end of high teens rate
- 04/28/22
- MasterCard sees FY22 net revenue up at high end of high teens rate
- 04/28/22
- MasterCard to be network on Verizon's small business credit card, CEO says
- 04/29/22
- LianBio announces FDA approved Camzyos
- 04/27/22
- MeiraGTx appoints Debra Yu to board of directors
- 04/07/22
- LianBio partner ReViral expected to be acquired by Pfizer
- 04/07/22
- LianBio appoints Chen to board of directors
- 04/06/22
- JD.com names Lei Xu as new CEO
- 03/13/22
- Fly Intel: Top five weekend stock stories
- 03/13/22
- JD.com announces proposed acquisition of Deppon Logistics by JD Logistics
- 04/28/22
- Intel CEO: Q1 was a strong start to the year, exceeded expectations
- 04/28/22
- Intel reaffirms FY22 revenue guidance
- 04/25/22
- Tower Semiconductor shareholders approve Intel merger agreement
- 04/20/22
- Semtech announces Julie McGee as chief marketing officer
- 04/26/22
- HSBC: Revenue outlook remains 'positive,' sees MSD revenue growth in 2022
- 04/18/22
- Plug Power appoints Jean Bua, Kavita Mahtani to board of directors
- 03/29/22
- HSBC, IBM to explore applications for quantum computing in financial services
- 03/16/22
- HSBC Bank USA, affiliates raise prime and reference rate to 3.5% from 3.25%
- 04/13/22
- Honeywell announces new sustainability commitments
- 03/25/22
- Brady secures license to Honeywell global shutter barcode technology
- 03/09/22
- Honeywell suspends substantially all business in Russia, Belarus
- 03/08/22
- Honeywell, DESS partner on energy resiliency solutions
- 12/07/21
- Stellantis to create family of semiconductors with Hon Hai Precision
- 11/10/21
- Lordstown, Foxconn enter into definitive purchase agreement over Ohio facility
- 11/10/21
- Lordstown Motors appoints Edward Hightower as president
- 04/28/22
- Fortune Brands announces intent to separate into two separate companies
- 04/28/22
- Fortune Brands announces intent to separate into two separate companies
- 03/02/22
- Fortune Brands announces $750M share repurchase authorization
- 02/07/22
- Fortune Brands names May Russell chief digital officer
- 04/29/22
- Eldorado Gold falls -10.7%
- 04/28/22
- Eldorado Gold still sees 2022 gold production 460K-490K oz.
- 04/13/22
- Eldorado Gold reports preliminary Q1 gold production 93,209 ounces
- 02/24/22
- Eldorado Gold sees 2022 gold production 460K-490K
- 04/29/22
- Chevron sees FY22 CapEx more than 50% higher than FY21
- 04/29/22
- Chevron reports Q1 cash flow from operations $8.1B, free cash flow $6.1B
- 04/26/22
- Lincoln Electric collaborates with Chevron for refinery maintenance
- 03/20/22
- Fly Intel: Top five weekend stock stories
- 04/27/22
- Comcast, Charter form joint venture to develop streaming platform
- 04/26/22
- Nintendo says 'Mario Bros.' movie pushed by Spring 2023
- 04/24/22
- Fly Intel: Top five weekend stock stories
- 04/20/22
- Comcast announces $1M investment in Backstage Capital
- 04/29/22
- Clearwater Paper rises 21.1%
- 04/29/22
- Clearwater Paper rises 17.0%
- 04/28/22
- Clearwater Paper sees Q2 adjusted EBITDA of $54M-$64M
- 04/28/22
- Clearwater Paper says resuming previously approved buyback
- 04/01/22
- Carlyle enters into strategic advisory services agreement with Fortitude Re
- 03/09/22
- Carlyle Group to acquire CBAM Partners' portfolio of assets
- 03/07/22
- AZZ Inc. to acquire Precoat Metals from Sequa Corporation for $1.28B
- 02/14/22
- Apollo Global to acquire majority stake in Novolex, terms not disclosed
- 04/28/22
- FDA approves Bristol-Myers' Camzyos in adults with obstructive HCM
- 04/18/22
- Bristol-Myers to begin including R&D charges with Q1, sees 10c impact from IPRD
- 04/14/22
- Nektar, Bristol-Myers to end development program for bempegaldesleukin/Opdivo
- $100.62 /
+9.78 (+10.77%) - 03/22/22
- Alibaba up 9.5% to $113.40 after the company expanded its buyback to $25B
- 03/21/22
- Alibaba increases stock buyback program to $25B from $15B
- 03/10/22
- BeiGene, Yum China, Zai Lab, ACM Research, Hutchmed named to SEC HFCAA list
- 02/17/22
- Atlas Air, Cainiao expand partnership with Boeing Freighter
- 02/15/22
- Avantor chairman Rajiv Gupta to retire
- 02/11/22
- Avantor starts construction on new distribution center in Ireland
- 11/15/21
- Third Point buys Alight, exits Uber in Q3
- $2,520.02 /
-366.49 (-12.70%) - 04/29/22
- Victoria's Secret & PINK Beauty launch in Amazon's store
- 04/28/22
- Amazon.com says customer demand 'remains strong'
- 04/28/22
- Amazon.com says Prime members continue to be key driver of growth
- 04/28/22
- Amazon down 10% after Q1 report, Q2 guidance
- 04/13/22
- Accolade announces partnership with Priority Health
- $142.37 /
-14.02 (-8.96%) - 04/29/22
- AbbVie says no plans to cut R&D investments in 2023
- 04/29/22
- AbbVie says cystic fibrosis combination drug missed study goal
- 04/29/22
- AbbVie says confident in long-term fundamentals of business
- 04/29/22
- AbbVie reports Q1 adjusted gross margin 84.5%
- 04/28/22
- Apple says COVID is 'difficult to predict'
- 04/28/22
- Apple turns lower, down nearly 4% in after-hours amid quarterly call
- 04/28/22
- Apple says iPhone acting install base reached new all-time high
- 04/28/22
- Apple shares rally 2% to $167.10 following Q2 beat, buyback raise
- 04/29/22 Evercore ISI
- Apple still well positioned for low double digit EPS growth, says Evercore ISI
- 04/29/22 Wells Fargo
- Apple's Q2 results 'solid' amid worsening supply chain impacts, says Wells Fargo
- 04/29/22 Baird
- Apple weakness would be a buying opportunity, says Baird
- 04/29/22 Deutsche Bank
- Apple price target lowered to $200 from $210 at Deutsche Bank
- $2,520.02 /
-366.49 (-12.70%) - 04/29/22 Truist
- Amazon.com price target lowered to $3,500 from $4,000 at Truist
- 04/29/22 Evercore ISI
- Amazon price target lowered to $4,100 from $4,300 at Evercore ISI
- 04/29/22 DA Davidson
- Amazon.com price target lowered to $3,125 from $3,900 at DA Davidson
- 04/29/22 BMO Capital
- Amazon.com price target lowered to $3,450 from $3,650 at BMO Capital
- $905.80 /
+28.79 (+3.28%) - 04/27/22 Wedbush
- Twitter transaction 'was never ideal' for Tesla investors, says Wedbush
- 04/26/22 Wedbush
- 'Soap opera' now ends with Musk owning Twitter, says Wedbush
- 04/25/22 Gordon Haskett
- Twitter bid more attractive after market selloff, says Gordon Haskett
- 04/25/22 Wedbush
- Twitter bid unlikely to result in major sale of Musk's Tesla stock, says Wedbush
- 04/29/22 Evercore ISI
- Evercore 'impressed' by Snap's product innovation after partner summit
- 04/28/22 Piper Sandler
- Twitter price target raised to $51.50 from $46 at Piper Sandler
- 04/26/22 Wedbush
- Twitter price target raised to $54 from $42 at Wedbush
- 04/29/22 Northland
- Intel Q2 guidance looks conservative, says Northland
- 04/27/22 Lynx
- Lynx sees China supply risks extending into Q3
- 04/14/22 Credit Suisse
- TSMC results may give 'tactical reprieve' to U.S. Semis, says Credit Suisse
- 04/12/22 Citi
- Citi sees 'another yellow flag' for Intel, reiterates Neutral
- 04/21/22 Truist
- Chevron price target raised to $186 from $160 at Truist
- 04/21/22 RBC Capital
- Chevron downgraded to Sector Perform from Outperform at RBC Capital
- 04/05/22 UBS
- Chevron price target raised to $192 from $150 at UBS
- 03/14/22 Morgan Stanley
- Chevron downgraded to Equal Weight at Morgan Stanley after outperformance
- $100.62 /
+9.78 (+10.77%) - 04/11/22 UBS
- Alibaba price target lowered to $140 from $150 at UBS
- 04/10/22 Goldman Sachs
- Alibaba assumed with a Buy at Goldman Sachs
- 04/08/22 HSBC
- Alibaba price target lowered to $156 from $168 at HSBC
- 04/07/22 Benchmark
- Alibaba price target lowered to $220 from $235 at Benchmark
- 04/29/22 86 Research
- Pinduoduo upgraded to Buy from Hold at 86 Research
- 04/10/22 Goldman Sachs
- Pinduoduo assumed with a Buy at Goldman Sachs
- 03/23/22 UBS
- UBS upgrades Pinduoduo to Buy on gross margin expansion offsetting slower growth
- 03/23/22 UBS
- Pinduoduo upgraded to Buy from Neutral at UBS
- 04/13/22 CLSA
- JD.com price target lowered to $100 from $108 at CLSA
- 03/16/22 US Tiger
- China Internet sector upgraded to Outperform from Neutral at US Tiger
- 03/14/22 JPMorgan
- JPMorgan downgrades Dada Nexus to Neutral, prefers over smaller peer Dingdong
- 03/14/22 JPMorgan
- JD.com downgraded to Underweight from Overweight at JPMorgan
- $23.63 /
+2.375 (+11.17%) - 04/10/22 Goldman Sachs
- Weibo assumed with a Neutral at Goldman Sachs
- 03/14/22 JPMorgan
- Weibo price target lowered to $24 from $32 at JPMorgan
- 03/11/22 UBS
- Weibo downgraded to Neutral at UBS on weaker ad growth and margin outlook
- 03/11/22 UBS
- Weibo downgraded to Neutral from Buy at UBS
- 04/27/22 Credit Suisse
- HSBC price target lowered to 515 GBp from 530 GBp at Credit Suisse
- 04/20/22 Barclays
- HSBC price target raised to 735 GBp from 725 GBp at Barclays
- 03/14/22 JPMorgan
- HSBC price target lowered to 510 GBp from 570 GBp at JPMorgan
- 03/04/22 RBC Capital
- HSBC price target raised to 570 GBp from 530 GBp at RBC Capital
- 04/21/22 Benchmark
- Roku price target lowered to $240 from $305 at Benchmark
- 04/21/22 Citi
- Netflix price target lowered to $295 from $450 at Citi
- 04/21/22 Edward Jones
- Netflix downgraded to Hold from Buy at Edward Jones
- 04/21/22 DZ Bank
- Netflix downgraded to Hold from Buy at DZ Bank
- 03/14/22 BofA
- Apple exposure to Shenzhen and Suzhou 'manageable,' says BofA
- 11/12/21 R.F. Lafferty
- R.F. Lafferty upgrades Lordstown to Hold on better odds for Endurance production
- 03/15/22 Evercore ISI
- Zymeworks initiated with an Outperform at Evercore ISI
- 02/28/22 Piper Sandler
- Piper Sandler recommends ALX Oncology shares following 'quiet' Q4
- 02/28/22 Citi
- Zymeworks price target lowered to $30 from $53 at Citi
- 02/09/22 Wells Fargo
- Zymeworks price target lowered to $45 from $56 at Wells Fargo
- 03/09/22 Daiwa
- TAL Education upgraded to Buy from Neutral at Daiwa
- 03/07/22 Morgan Stanley
- Youdao upgraded to Overweight from Equal Weight at Morgan Stanley
- 03/07/22 Morgan Stanley
- TAL Education upgraded to Overweight from Underweight at Morgan Stanley
- 04/14/22 JPMorgan
- Olin added to Analyst Focus List at JPMorgan
- 03/14/22 KeyBanc
- KeyBanc upgrades Olin to Overweight with $64 price target
- 03/14/22 KeyBanc
- Olin upgraded to Overweight from Sector Weight at KeyBanc
- 01/31/22 Fermium Research
- Olin price target raised to $70 from $60 at Fermium Research
- $142.67 /
+11.86 (+9.07%) - 04/21/22 Wells Fargo
- Mohawk Industries price target lowered to $135 from $155 at Wells Fargo
- 04/20/22 JPMorgan
- Mohawk Industries price target lowered to $127 from $140 at JPMorgan
- 04/12/22 Loop Capital
- Mohawk Industries price target lowered to $130 from $165 at Loop Capital
- 04/05/22 Credit Suisse
- Mohawk Industries initiated with a Neutral at Credit Suisse
- 04/19/22 Cowen
- Avantor price target lowered to $44 from $50 at Cowen
- 04/18/22 Evercore ISI
- Avantor added to 'TAP Outperform' list at Evercore ISI
- 04/04/22 Evercore ISI
- Avantor price target lowered, removed from 'TAP Outperform' list at Evercore ISI
- 04/04/22 Citi
- Avantor downgraded to Neutral on 'number of headwinds' at Citi
- 11/26/21 BofA
- LianBio initiated with a Buy at BofA
- 11/26/21 Goldman Sachs
- LianBio initiated with a Neutral at Goldman Sachs
- 11/26/21 Jefferies
- LianBio initiated with a Buy at Jefferies
- 11/24/21 Raymond James
- LianBio initiated with an Outperform at Raymond James
- 04/29/22 SVB Securities
- Accolade downgraded to Market Perform from Outperform at SVB Leerink
- 04/29/22 Stifel
- Accolade removed from 'Select List,' price target lowered to $16 at Stifel
- 04/29/22 Canaccord
- Accolade price target lowered to $17 from $34 at Canaccord
- 04/29/22 Needham
- Accolade price target lowered to $12 from $33 at Needham
- 04/29/22 Citi
- Citi downgrades Western Union to Neutral, sees shares being range-bound
- 04/29/22 Citi
- Western Union downgraded to Neutral from Buy at Citi
- 04/29/22 JPMorgan
- Western Union price target lowered to $19 from $20 at JPMorgan
- 03/31/22 UBS
- Western Union initiated with a Neutral at UBS
- 04/20/22 National Bank
- Eldorado Gold price target raised to C$20 from C$18 at National Bank
- 02/08/22 Stifel
- Eldorado Gold price target lowered to C$20.25 from C$21.50 at Stifel
- 02/04/22 National Bank
- Eldorado Gold price target raised to C$17 from C$16 at National Bank
- 01/19/22 National Bank
- Eldorado Gold price target lowered to C$16 from C$17.50 at National Bank
- 04/14/22 Deutsche Bank
- Honeywell price target lowered to $230 from $243 at Deutsche Bank
- 04/14/22 Deutsche Bank
- Honeywell named short-term buy idea at Deutsche Bank
- 03/28/22 Cowen
- Honeywell first half consensus may be too high, says Cowen
- 03/04/22 Deutsche Bank
- Honeywell price target raised to $243 from $237 at Deutsche Bank
- $142.37 /
-14.02 (-8.96%) - 04/29/22 Piper Sandler
- AbbVie data miss removes primary Vertex overhang, says Piper Sandler
- 04/25/22 BMO Capital
- AbbVie price target raised to $174 from $161 at BMO Capital
- 04/22/22 Piper Sandler
- Biohaven widening lead over AbbVie in migraine, says Piper Sandler
- 04/14/22 JPMorgan
- Royalty Pharma upgraded to Overweight on valuation at JPMorgan
- 04/11/22 Macquarie
- Wipro initiated with a Neutral at Macquarie
- 02/21/22 CLSA
- Wipro upgraded to Outperform from Underperform at CLSA
- 02/04/22 Jefferies
- Wipro upgraded to Hold yesterday at Jefferies following 20% correction
- 02/03/22 Jefferies
- Wipro upgraded to Hold from Underperform at Jefferies
- 04/29/22 BMO Capital
- Carlyle Group price target lowered to $60 from $69 at BMO Capital
- 04/22/22 BMO Capital
- Blackstone price target raised to $142 from $124 at BMO Capital
- 04/13/22 Oppenheimer
- Carlyle Group price target raised to $80 from $71 at Oppenheimer
- 04/13/22 Oppenheimer
- Oppenheimer upgrades Apollo Global following 23% year-to-date pullback
- 02/16/22 BMO Capital
- Clearwater Paper upgraded to Outperform at BMO amid 'overdone' move lower
- 02/16/22 BMO Capital
- Clearwater Paper upgraded to Outperform from Market Perform at BMO Capital
- 02/16/22 RBC Capital
- Clearwater Paper cut to Sector Perform at RBC Capital on likely lower cash flow
- 02/16/22 RBC Capital
- Clearwater Paper downgraded to Sector Perform from Outperform at RBC Capital
- 04/29/22 BMO Capital
- MasterCard price target lowered to $402 from $412 at BMO Capital
- 04/29/22 Deutsche Bank
- MasterCard price target raised to $440 from $420 at Deutsche Bank
- 04/29/22 Citi
- MasterCard price target raised to $453 from $435 at Citi
- 04/29/22 JPMorgan
- MasterCard price target raised to $430 from $400 at JPMorgan
- 04/29/22 Morgan Stanley
- Comcast price target lowered to $55 from $60 at Morgan Stanley
- 04/29/22 Deutsche Bank
- Comcast price target lowered to $60 from $62 at Deutsche Bank
- 04/29/22 BTIG
- Accolade downgraded to Neutral from Buy at BTIG
- 04/26/22 Barclays
- Rivian Automotive price target lowered to $38 from $42 at Barclays
- 04/25/22 JPMorgan
- Ford price target lowered to $21 from $22 at JPMorgan
- 04/21/22 Deutsche Bank
- Rivian Automotive price target lowered to $90 from $91 at Deutsche Bank
- 04/20/22 Mizuho
- Rivian Automotive price target lowered to $90 from $95 at Mizuho
- 04/29/22 Benchmark
- Benchmark 'incrementally more confident' in improving Roku growth after Q1
- 04/29/22 DA Davidson
- Roku price target lowered to $170 from $200 at DA Davidson
- 04/29/22 Stephens
- Roku price target lowered to $190 from $230 at Stephens
- 04/29/22 Oppenheimer
- Roku price target lowered to $155 from $185 at Oppenheimer
- 04/29/22 Truist
- Fortune Brands price target lowered to $100 from $115 at Truist
- 04/29/22 BofA
- Fortune Brands upgraded to Neutral at BofA on cabinets spinoff plan
- 04/29/22 BofA
- Fortune Brands upgraded to Neutral from Underperform at BofA
- 04/29/22 KeyBanc
- Fortune Brands downgraded to Sector Weight from Overweight at KeyBanc
- 04/18/22 Goldman Sachs
- Nektar downgraded to Sell from Neutral at Goldman Sachs
- 04/18/22 Mizuho
- Nektar price target lowered to $6 from $8 at Mizuho
- 04/06/22 Morgan Stanley
- Bristol-Myers assumed with an Underweight at Morgan Stanley
- 03/30/22 BMO Capital
- Bristol-Myers price target raised to $81 from $74 at BMO Capital
- 02/24/22
- Zymeworks reports Q4 EPS (95c), consensus ($1.14)
- 11/03/21
- Zymeworks reports Q3 EPS ($1.25), consensus ($1.17)
- 04/28/22
- Western Union cuts FY22 adjusted EPS view to $1.75-$1.85 from $1.90-$2.00
- 04/28/22
- Western Union reports Q1 adjusted EPS 51c, consensus 43c
- 02/10/22
- Western Union sees FY22 adjusted EPS $1.90-$2.00, consensus $2.24
- 04/29/22
- Wipro reports Q4 EPS 7c, two estimates 8c
- 01/12/22
- Wipro reports Q3 EPS 7c, consensus 8c
- $23.63 /
+2.375 (+11.17%) - 03/03/22
- Weibo reports Q4 EPS 83c, consensus 81c
- 11/11/21
- Weibo sees Q4 revenue up 15%-20%, consensus $594.3M
- 11/11/21
- Weibo reports Q3 EPS 90c, consensus 84c
- 04/28/22
- Twitter withdrawing previously provided outlook given pending acquisition
- 04/28/22
- Twitter reports Q1 EPS 90c, consensus 3c
- 02/10/22
- Twitter expects FY22 revenue growth in low to mid 20's range
- 02/10/22
- Twitter sees Q1 revenue $1.17B-$1.27B, consensus $1.26B
- $905.80 /
+28.79 (+3.28%) - 04/20/22
- Tesla reports Q1 EPS $3.22, consensus $2.26
- 04/20/22
- Notable companies reporting after market close
- 01/26/22
- Tesla reports Q4 non-GAAP EPS $2.54, consensus $2.26
- 01/26/22
- Notable companies reporting after market close
- 04/29/22
- TAL Education reports Q4 EPS (17c), consensus (12c)
- 02/22/22
- TAL Education reports Q3 EPS 9c, consensus 3c
- 04/28/22
- Roku backs FY22 revenue growth view of 35% y/y, consensus $3.72B
- 04/28/22
- Roku sees Q2 revenue $805M, consensus $815.7M
- 04/28/22
- Roku reports Q1 EPS (19c), consensus (18c)
- 03/10/22
- Rivian sees FY22 adjusted EBITDA ($4.75B)
- 03/10/22
- Rivian reports Q4 EPS ($4.83) vs ($1.97)
- 03/10/22
- Notable companies reporting after market close
- 03/21/22
- Pinduoduo reports Q4 EPS RMB 5.88 vs. (RMB 0.15) last year
- 11/26/21
- Pinduoduo reports Q3 adjusted EPS 34c, consensus 2c
- 04/28/22
- Olin reports Q1 EPS $2.48, consensus $2.35
- 01/27/22
- Olin sees FY22 adjusted EBITDA $2.5B-$2.8B
- 01/27/22
- Olin reports Q4 EPS $1.89, consensus $2.44
- 04/19/22
- Netflix sees Q2 EPS $3.00, consensus $3.01
- 04/19/22
- Netflix reports Q1 EPS $3.53, consensus $2.90
- 04/19/22
- Notable companies reporting after market close
- 01/20/22
- Netflix sees Q1 EPS $2.86, consensus $3.45
- $142.67 /
+11.86 (+9.07%) - 04/28/22
- Mohawk Industries reports Q1 adjusted EPS $3.78, consensus $2.90
- 02/10/22
- Mohawk Industries sees Q1 adjusted EPS $2.90-$3.00, consensus $3.08
- 02/10/22
- Mohawk Industries reports Q4 adjusted EPS $2.95, consensus $2.87
- 04/28/22
- MasterCard reports Q1 adjusted EPS $2.76, consensus $2.17
- 04/27/22
- Notable companies reporting before tomorrow's open
- 01/27/22
- MasterCard sees Q1 net revenue up in the high teens, consensus $5.07B
- 03/30/22
- LianBio reports Q4 EPS (28c), consensus (71c)
- 12/09/21
- LianBio reports Q3 EPS (63c), consensus (57c)
- 03/10/22
- JD.com reports Q4 EPS 35c, consensus 24c
- 11/18/21
- JD.com reports Q3 EPS 25c, consensus 32c
- 11/17/21
- Notable companies reporting before tomorrow's open
- 04/28/22
- Intel sees FY22 adjusted EPS $3.60, consensus $3.50
- 04/28/22
- Intel sees Q2 adjusted EPS 70c, consensus 83c
- 04/28/22
- Intel reports Q1 adjusted EPS 87c, consensus 80c
- 04/26/22
- HSBC reports Q1 EPS 14c vs. 19c last year
- 02/23/22
- HSBC reports 2021 EPS 62c vs. 19c last year
- 04/29/22
- Honeywell sees Q2 adjusted EPS $1.98-$2.08, consensus $2.04
- 04/29/22
- Honeywell raises FY22 adjusted EPS view to $8.50-$8.80 from $8.40-$8.70
- 04/29/22
- Honeywell reports Q1 adjusted EPS $1.91, consensus $1.86
- 04/28/22
- Fortune Brands now sees FY22 EPS $6.40-$6.60, consensus $6.40
- 04/28/22
- Fortune Brands reports Q1 adjusted EPS $1.31, consensus $1.26
- 02/02/22
- Fortune Brands sees FY22 EPS $6.35-$6.55, consensus $6.31
- 04/28/22
- Eldorado Gold reports Q1 adjusted EPS (10c), consensus 7c
- 02/24/22
- Eldorado Gold reports Q4 EPS (24c), consensus 13c
- 04/29/22
- Chevron reports Q1 adjusted EPS $3.36, consensus $3.27
- 04/28/22
- Notable companies reporting before tomorrow's open
- 01/28/22
- Chevron reports Q4 adjusted EPS $2.56, consensus $3.13
- 04/28/22
- Comcast reports Q1 adjusted EPS 86c, consensus 80c
- 01/27/22
- Comcast reports Q4 adjusted EPS 77c, consensus 73c
- 04/28/22
- Clearwater Paper reports Q1 EPS 97c, consensus 87c
- 02/15/22
- Clearwater Paper reports Q4 EPS 82c, consensus 79c
- 11/02/21
- Clearwater Paper sees FY21 adjusted EBITDA $167M-$175M
- 11/02/21
- Clearwater Paper sees Q4 adjusted EBITDA $48M-$56M
- 04/29/22
- Carlyle Group reports Q1 EPS 74c vs. 58c last year
- 02/02/22
- Notable companies reporting before tomorrow's open
- 04/29/22
- Bristol-Myers lowers FY22 adjusted EPS view to $7.44-$7.74 from $7.65-$7.95
- 04/29/22
- Bristol-Myers reports Q1 EPS $1.96, consensus $1.91
- $100.62 /
+9.78 (+10.77%) - 02/24/22
- Alibaba reports Q4 EPS $2.65, consensus $2.55
- 02/23/22
- Notable companies reporting before tomorrow's open
- 11/18/21
- Alibaba now sees FY22 revenue to grow 20%-23% year-over-year
- 04/28/22
- Avantor reports Q1 adjusted EPS 38c, consensus 36c
- 02/03/22
- Avantor reports Q4 adjusted EPS 36c, consensus 33c
- $2,520.02 /
-366.49 (-12.70%) - 04/28/22
- Amazon sees Q2 revenue $116B-$121B, consensus $125.55B
- 04/28/22
- Amazon reports Q1 EPS ($7.56) with Rivian expense, consensus $8.36
- 04/26/22
- Else Nutrition sees Q1 revenue top end of C$1.45M-C$1.6M
- 04/28/22
- Accolade sees FY23 revenue $350M-$365M, consensus $387.39M
- 04/28/22
- Accolade sees Q2 revenue $81M-$83M, consensus $85.91M
- 04/28/22
- Accolade reports Q4 EPS (51c), consensus (36c)
- $142.37 /
-14.02 (-8.96%) - 04/29/22
- AbbVie sees FY22 revenue $59.4B, consensus $60.22B
- 04/29/22
- AbbVie sees Q2 adjusted EPS $3.38-$3.42, consensus $3.50
- 04/29/22
- AbbVie cuts FY22 adjusted EPS view to $13.92-$14.12 from $14.00-$14.20
- 04/29/22
- AbbVie reports Q1 adjusted EPS $3.16, consensus $3.14
- 04/28/22
- Apple says y/y Q3 revenue growth to be impacted by COVID
- 04/28/22
- Apple reports Q2 EPS $1.52, consensus $1.43
- 04/28/22
- Notable companies reporting after market close
- 02/27/22
- Berkshire operating earnings surge, Buffett repurchases record $27B in stock
|
|
Earnings
|
Reports Q1 revenue… Reports Q1 revenue $1.95B, consensus $1.93B. "Avantor kicked off 2022 with another strong quarter across all key financial metrics. Despite a challenging macroeconomic environment, we continued our track record of execution by delivering core organic growth of 7.3% and approximately 140 basis points in Adjusted EBITDA margin expansion. Ongoing momentum in our end markets is encouraging, particularly in Biopharma, where we realized more than 20% growth in bioproduction," said CEO Michael Stubblefield. "We are successfully advancing our long-term growth strategy by consistently meeting the evolving needs of our global customer base and enabling scientific breakthroughs that create value for all stakeholders. The investments we made during the quarter in manufacturing capacity and innovation, as well as the strong contributions we are realizing from our three recent acquisitions are fortifying our position as a life sciences leader. This continued strong performance gives us increased confidence in our full year outlook and we are raising our adjusted EPS guidance range." ShowHide Related Items >><< - 02/15/22
- Avantor chairman Rajiv Gupta to retire
- 02/11/22
- Avantor starts construction on new distribution center in Ireland
- 11/15/21
- Third Point buys Alight, exits Uber in Q3
- 04/19/22 Cowen
- Avantor price target lowered to $44 from $50 at Cowen
- 04/18/22 Evercore ISI
- Avantor added to 'TAP Outperform' list at Evercore ISI
- 04/04/22 Evercore ISI
- Avantor price target lowered, removed from 'TAP Outperform' list at Evercore ISI
- 04/04/22 Citi
- Avantor downgraded to Neutral on 'number of headwinds' at Citi
- 02/03/22
- Avantor reports Q4 adjusted EPS 36c, consensus 33c
|
|
Recommendations
|
Craig-Hallum analyst Matt… Craig-Hallum analyst Matt Hewitt lowered the firm's price target on Repligen to $274 from $286 and keeps a Buy rating on the shares. Overall, the analyst would characterize Repligen's Q1 earnings report as better than investors had feared. While there was a long list of worries that investors had going into the quarter, Hewitt believes most of these were adequately addressed by the company. ShowHide Related Items >><< - $157.37 /
+15.11 (+10.62%) - 03/02/22
- 908 Devices appoints Repligen CEO Tony Hunt to board
- 02/15/22
- Repligen launches AAV affinity resins for gene therapy purification
- 11/11/21
- AirBNB, DoorDash, Coinbase, Affirm Holdings among names added to U.S. MSCI
- 11/05/21
- Repligen releases inaugural sustainability report
- $157.37 /
+15.11 (+10.62%) - 02/18/22 SVB Securities
- Repligen price target lowered to $250 from $275 at SVB Leerink
- 11/26/21 Benchmark
- Recent deals highlight value in ImmunoPrecise shares, says Benchmark
- 10/14/21 Exane BNP Paribas
- Repligen initiated with an Outperform at Exane BNP Paribas
- 09/27/21 Craig-Hallum
- Repligen price target raised to $368 from $258 at Craig-Hallum
- $157.37 /
+15.11 (+10.62%) - 04/27/22
- Repligen lowers FY22 adjusted EPS view to $3.07-$3.15 from $3.21-$3.30
- 04/27/22
- Repligen reports Q1 EPS 81c, consensus 72c
- 02/17/22
- Repligen sees 2022 adjusted EPS $3.21-$3.30, consensus $3.15
- 02/17/22
- Repligen reports Q4 adjusted EPS 81c, consensus 65c
|
|
Earnings
|
Consensus $9.28. Backs… Consensus $9.28. Backs FY22 revenue view $3.05B-$3.08B, consensus $3.07B. The company said, "Full-year 2022 capital spending is expected to be $380 million. This includes incremental capital spending to support capacity expansions at existing HVP facilities." ShowHide Related Items >><< - 04/07/22
- West Pharmaceutical partners with Pneuma Systems for drug delivery solutions
- 02/28/22
- West Pharmaceutical names Eric Green as Chair of Board
- 01/25/22
- West Pharmaceutical enters supply, technology agreement with Corning
- 04/28/22
- West Pharmaceutical reports Q1 EPS $2.30, consensus $2.12
- 02/17/22
- West Pharmaceutical sees FY22 EPS $9.20-$9.35, consensus $9.06
- 02/17/22
- West Pharmaceutical reports Q4 adjusted EPS $2.04, consensus $1.91
- 11/26/21
- Early notable gainers among liquid option names on November 26th
- 11/16/21
- Early notable gainers among liquid option names on November 16th
|
|
Earnings
|
Reports Q1 revenue $720M,… Reports Q1 revenue $720M, consensus $720.92M. "We delivered a solid first-quarter 2022 and remain on track to increase capacity throughout the year to satisfy the growing demand for our high-value products (HVP)," said Eric Green, president and CEO. "Our team members across the globe continue to demonstrate their passion to improve patient lives as they remain focused on executing our strategic initiatives despite macroeconomic challenges. Even with these challenges, and headwinds related to changes in foreign currency exchange rates, we remain well positioned for continued net sales growth and margin expansion. We are reaffirming our full-year 2022 net sales guidance, raising our full-year organic sales growth guidance, and raising our full-year 2022 adjusted-diluted EPS guidance." ShowHide Related Items >><< - 04/07/22
- West Pharmaceutical partners with Pneuma Systems for drug delivery solutions
- 02/28/22
- West Pharmaceutical names Eric Green as Chair of Board
- 01/25/22
- West Pharmaceutical enters supply, technology agreement with Corning
- 02/17/22
- West Pharmaceutical sees FY22 EPS $9.20-$9.35, consensus $9.06
- 02/17/22
- West Pharmaceutical reports Q4 adjusted EPS $2.04, consensus $1.91
- 11/26/21
- Early notable gainers among liquid option names on November 26th
- 11/16/21
- Early notable gainers among liquid option names on November 16th
|
